Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
Kappa and Lambda Light Chains - HealthTree for Multiple Myeloma
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Kappa/lambda ratio : r/multiplemyeloma
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Is accuracy of serum free light chain measurement achievable?
Disease spectrum of abnormal serum free light chain ratio and its diagnostic significance | Oncotarget
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Mom has high kappa light chain. Very anemic. Doctors want to wait and follow up later. She's getting quite tired and losing appetite. She broke her femur a year ago too. :
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal